Brinker Capital Inc. boosted its position in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 26.1% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 54,575 shares of the pharmacy operator’s stock after acquiring an additional 11,302 shares during the quarter. Brinker Capital Inc.’s holdings in Walgreens Boots Alliance were worth $3,019,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in WBA. Sageworth Trust Co acquired a new stake in Walgreens Boots Alliance in the 2nd quarter valued at about $27,000. First Interstate Bank raised its position in shares of Walgreens Boots Alliance by 228.1% during the 2nd quarter. First Interstate Bank now owns 607 shares of the pharmacy operator’s stock worth $33,000 after acquiring an additional 422 shares in the last quarter. TRUE Private Wealth Advisors acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth about $38,000. Golden State Wealth Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the 2nd quarter worth about $38,000. Finally, Hanson & Doremus Investment Management raised its position in shares of Walgreens Boots Alliance by 300.0% during the 2nd quarter. Hanson & Doremus Investment Management now owns 800 shares of the pharmacy operator’s stock worth $44,000 after acquiring an additional 600 shares in the last quarter. Institutional investors own 59.76% of the company’s stock.
Several equities research analysts have recently weighed in on WBA shares. Bank of America cut their target price on Walgreens Boots Alliance from $51.00 to $50.00 and set an “underperform” rating on the stock in a research report on Thursday, October 3rd. JPMorgan Chase & Co. cut their target price on Walgreens Boots Alliance from $74.00 to $73.00 and set an “overweight” rating on the stock in a research report on Friday, June 28th. Deutsche Bank started coverage on Walgreens Boots Alliance in a research report on Thursday, September 12th. They set a “sell” rating on the stock. Royal Bank of Canada lowered Walgreens Boots Alliance to a “hold” rating and set a $59.00 target price on the stock. in a research report on Friday, September 27th. Finally, Cleveland Research reissued a “hold” rating on shares of Walgreens Boots Alliance in a research report on Monday, September 9th. Seven research analysts have rated the stock with a sell rating, twelve have given a hold rating and three have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $62.24.
WBA opened at $55.32 on Wednesday. The firm has a market cap of $49.94 billion, a price-to-earnings ratio of 9.19, a price-to-earnings-growth ratio of 1.41 and a beta of 0.89. Walgreens Boots Alliance Inc has a 52 week low of $49.03 and a 52 week high of $86.31. The business’s 50 day moving average is $54.10 and its two-hundred day moving average is $53.31. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.